CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...
3d
News-Medical.Net on MSNBreakthrough peptide inhibitor effective against multiple SARS-CoV-2 variantsSARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.
3-Deazapurine ribonucleoside shows potent preclinical anti-SARS-CoV-2 activity, preventing pneumonia
Although several vaccines and drugs are available against SARS-CoV-2, the search for effective therapeutic agents for COVID-19 and future zoonotic coronaviruses continues. The RNA-dependent RNA ...
5d
AZoLifeSciences on MSNBispecific antibodies for SARS-CoV-2 variant neutralizationBispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...
Here the authors characterise the cellular and molecular progression of lung alveolar damage in severe COVID-19 patients using integrated histopathology and cell atlassing, pinpointing a role for ...
Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...
Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...
Long Covid often goes undiagnosed, leaving many unaware of their condition. Learn about its symptoms, risks, and the importance of early diagnosis.
On March 11, 2020, the World Health Organization declared COVID-19 a pandemic. According to official data, there have been ...
In Kolkata, West Bengal, a 49-year-old lady contracted the human coronavirus HKU1. The hospital reports that the patient was admitted after a 15-day period of a persistent fever ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results